Targeting Primary Ciliogenesis with Small-Molecule Inhibitors

Area of Science:

• Cell Biology
• Developmental Biology
• Cancer Biology

Background:

• The primary cilium is a non-motile, microtubule-based organelle crucial for cell signaling.
• It regulates essential cellular processes like proliferation and differentiation.
• Dysfunctional primary cilia are linked to ciliopathies and cancer development.

Purpose of the Study:

• To review pharmacological inhibitors of primary ciliogenesis.
• To discuss their utility in studying primary cilium biology.
• To evaluate their potential for treating ciliopathies and cancers.

Main Methods:

• Literature review of pharmacological inhibitors affecting cilium assembly.
• Analysis of inhibitors' impact on cellular processes.
• Discussion of tools for disease treatment.

Main Results:

• Pharmacological inhibitors of ciliogenesis have been identified.
• These tools impact both cilium assembly and other cellular functions.
• Their value and limitations in research and therapy are discussed.

Conclusions:

• Pharmacological inhibition of primary ciliogenesis is a promising therapeutic strategy.
• Further research is needed to understand the full potential and limitations of these inhibitors.
• Targeting primary cilia offers a novel approach for treating ciliopathies and cancers.